Viewing Study NCT00740103

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:47 PM
Ignite Modification Date: 2026-02-18 @ 10:37 AM
Study NCT ID: NCT00740103
Status: COMPLETED
Last Update Posted: 2025-03-28
First Post: 2008-08-21
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Long-term Study of Semapimod (CNI-1493) for Treatment of Crohn's Disease
Sponsor: Ferring Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Crohn's Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Semapimod View
None Crohn's Disease View
None TNF-alpha inhibitor View
None MAP Kinase inhibitor View
None CNI-1493 View